Imbruvica (ibrutinib) - AbbVie, J&J
Jaypirca (pirtobrutinib) - Eli Lilly
Calquence (acalabrutinib) - AstraZeneca
Brukinsa (zanubrutinib) - BeOne Medicines
Lunsumio (mosunetuzumab-axgb) - Roche
http://clinicaltrials.gov/ct2/show/NCT07052695
 
Dec 16, 2025
 
Next